A clinicopathologic study of biliary intraductal papillary neoplasm.
- Author:
	        		
		        		
		        		
			        		Tao LI
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Jia FAN
			        		
			        		;
		        		
		        		
		        		
			        		San-yuan HU
			        		
			        		;
		        		
		        		
		        		
			        		Zhao-you TANG
			        		
			        		;
		        		
		        		
		        		
			        		Xu-ting ZHI
			        		
			        		
		        		
		        		
		        		
			        		
			        		Author Information
			        		
 - Publication Type:Journal Article
 - MeSH: Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; pathology; surgery; Carcinoma, Papillary; pathology; surgery; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prognosis; Retrospective Studies
 - From: Chinese Journal of Surgery 2010;48(7):488-491
 - CountryChina
 - Language:Chinese
 - 
		        	Abstract:
			       	
			       		
				        
				        	
OBJECTIVETo investigate the clinicopathologic features, diagnosis and treatment of biliary intraductal papillary neoplasm (IPN-B).
METHODSThe clinical, histopathological, treatment and prognosis data of 23 patients with IPN-B treated from January 1998 to December 2007 were retrospectively analyzed.
RESULTSThere were 13 male and 10 female, aged from 30 to 80 years [mean age was (61 +/- 12) years]. The clinical manifestation included 10 cases with asymptomatic, 7 cases with abdominal pain, 4 cases with jaundice, 1 case with emaciation, and 1 case with acute cholangitis, respectively. Nine patients were also associated with hepatolithiasis. The average diameter of the tumors was (6 +/- 4) cm, 4 lesions were located in the right lobe, 15 in the left lobe, and 4 in the extrahepatic bile duct. Histopathologically, there were 4 adenomas, 1 borderline neoplasm, 6 carcinomas in situ, and 12 carcinomas. All patients received operation;the mean duration of follow-up was (33 +/- 28) months. Overall 3-year and 5-year survival rates of IPN-B were 85.3% and 68.2% respectively.
CONCLUSIONSIPN-B represents a distinct clinicopathologic entity. Favorable prognosis for IPN-B is offered by curative resection.
 
            